Patient with Atopic Dermatitis' Needs for Self-management Support - Flexible Patient Centred Consultations
NCT06032403 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200
Last updated 2024-11-18
Summary
In this study, the investigators will conduct a controlled trial to investigate the effects of a flexible patient-centred consultation with a focus on self-management support, well-being, treatment content, and self-management skills in patients with atopic dermatitis.
The investigators will include 200 participants; 100 participants in a control group followed by 100 participants in an intervention group. The controlled trial will take place at the outpatient clinic at the Department of Dermatology and Allergy, Herlev-Gentofte Hospital and the daily management will be done by the project manager/Ph.d. student with support from the project group.
In the control group, participants will be provided with care as usual. This means participants will be seen by a doctor and new participants will get an additional nurse session focusing on therapeutic patient education (TPE) in atopic dermatitis. The consultations are scheduled at regular intervals of approximately three months but with alterations if the participant needs to be seen before.
In the intervention group, the set-up will be flexible patient-centred consultations. The first consultation for the participant will be with the doctor and depending on the participant's need, the following consultations can be scheduled with either a doctor- or a nurse consultation. After each consultation, it will be decided in collaboration between the healthcare professionals and the participant whether a nurse or a doctor consultation will be relevant next. The consultations (whether it is with the doctor or nurse) will be centered around the participant's choice of topics by use of an atopic dermatitis dialogue tool developed in the department. Additionally, the nurse consultation will focus on therapeutic patient education (TPE) in atopic dermatitis. The interval between consultations will depend on the participant's need
Conditions
Interventions
- BEHAVIORAL
-
flexible patient centred consultations
In the intervention group, the set-up will be flexible patient-centred consultations. The first consultation for the participant will be with the doctor and depending on the participant's need, the following consultations can be scheduled as either a doctor- or a nurse consultation. After each consultation, it will be decided in collaboration between the healthcare professionals and the participant whether a nurse or a doctor consultation will be relevant next. The consultations (whether it is with the doctor or nurse) will be centered around the participant's choice of topics by use of an atopic dermatitis dialogue tool developed in the department. Additionally, the nurse consultation will focus on therapeutic patient education (TPE) in atopic dermatitis. The interval between consultations will depend on the participant's need
Sponsors & Collaborators
-
Aage Bangs Fond
collaborator OTHER -
The Novo Nordic Foundation
collaborator OTHER -
Herlev and Gentofte Hospital
collaborator OTHER - collaborator INDUSTRY
-
Almirall, S.A.
collaborator INDUSTRY -
University Hospital, Gentofte, Copenhagen
lead OTHER
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- SEQUENTIAL
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-01-31
- Primary Completion
- 2025-08-31
- Completion
- 2025-08-31
Countries
- Denmark
Study Locations
More Related Trials
-
Effectiveness of Psychodermatologic Educational Modules on Atopic Dermatitis Patient Outcomes
NCT07009483 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
French Prospective Observational Study in Patients Eligible for Systemic Therapy for Atopic Dermatitis (AD)
NCT06837454 ·Status: RECRUITING
-
A Study to Assess the Disease Control of Moderate to Severe Atopic Dermatitis in Male and Female Participants of Atleast 12 Years Old Receiving Dupilumab Injections in Gulf Countries
NCT05214326 ·Status: COMPLETED
-
A Phase I Study of HY209 Gel in Healthy Male Volunteers for Atopic Dermatitis
NCT03492398 ·Status: COMPLETED ·Phase: PHASE1
-
A Psychoeducational Prevention for the Treatment of Atopic Dermatitis in Youth and Their Families
NCT02067234 ·Status: WITHDRAWN ·Phase: NA
-
Cognitive Behavior Therapy for Atopic Dermatitis
NCT02302625 ·Status: COMPLETED ·Phase: NA
-
Description of the Population With Moderate to Severe Atopic Dermatitis, Treated by Systemic Treatments and Needs Regarding Emollients
NCT06983561 ·Status: COMPLETED
-
DMT210 Topical Gel in the Treatment of Atopic Dermatitis
NCT02949960 ·Status: COMPLETED ·Phase: PHASE2
-
Bronchial Hyperreactivity in Atopic Dermatitis Patients - a 10 Year Follow-up
NCT00795496 ·Status: COMPLETED
-
A Trial of Antroquinonol in Patients With Atopic Dermatitis
NCT03622463 ·Status: COMPLETED ·Phase: PHASE2
-
A Multicenter Randomized Control Trial in Children With Moderate to Severe Atopic Dermatitis to Assess the Benefit of a Nurse-led One-to-one Education Program in Addition to Standard Care Compared to Standard Care Alone on the Long Term Control of Disease Severity at 6 Months
NCT02634905 ·Status: TERMINATED ·Phase: NA
-
Atopic Dermatitis (AD) and Food Allergy
NCT03168113 ·Status: COMPLETED
-
Efficacy/Safety Study to Explore a New Topical Formulation in Atopic Dermatitis
NCT01691209 ·Status: WITHDRAWN ·Phase: NA
-
Neuropsychologic Assessments of Dupilumab-Treated Adolescent Participants With Moderate-to-Severe Atopic Dermatitis
NCT05203380 ·Status: COMPLETED
-
A 24 Week Trial to Compare the Efficacy and Safety of Delgocitinib Cream 20 mg/g Twice-daily With Alitretinoin Capsules Once-daily in Adult Participants With Severe Chronic Hand Eczema
NCT05259722 ·Status: COMPLETED ·Phase: PHASE3
-
The Effectiveness of Tailored Messages on the Usage of Emollient in Patients With Atopic Dermatitis
NCT02343861 ·Status: COMPLETED ·Phase: NA
-
A Study Evaluating the Safety and Efficacy of QGE031 in Atopic Dermatitis Patients
NCT01552629 ·Status: COMPLETED ·Phase: PHASE2
-
Post-Marketing Clinical Follow-Up Trial to Evaluate the Performance and Safety of the Medical Device 047 TD Dermatitis Cream in Adults and Children With Atopic and Contact Dermatitis Symptoms Confirmed by Clinical Parameters
NCT07056569 ·Status: RECRUITING ·Phase: NA
-
A Study of ATI-502 Topical Solution for the Treatment of Atopic Dermatitis
NCT03585296 ·Status: COMPLETED ·Phase: PHASE2
-
Real-world Effectiveness Study of Long-term Treatment With Dupilumab in Participants ≥6 Years With Atopic Dermatitis
NCT06039241 ·Status: RECRUITING
-
Taking Into Account the Patient/Parent Preference in the Galenic Choice in Atopic Dermatitis. Feasibility and Impact on Treatment Adherence
NCT02193230 ·Status: COMPLETED
-
A Study to Confirm the Efficacy and Safety of Different Dupilumab Dose Regimens in Adults With Atopic Dermatitis (AD)
NCT02395133 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy/Safety Study to Explore a New Revised Topical Formulation in Atopic Dermatitis
NCT01948869 ·Status: COMPLETED ·Phase: NA
-
Anti-relapse Efficacy and Tolerance Assessment of a Cosmetic Cream for Very Dry, Irritated to Atopic Sensitive Skin.
NCT05575882 ·Status: RECRUITING ·Phase: NA
-
Study of Immunoadsorption to Treat Severe Atopical Dermatitis Associated With Excessively High Serum IgE Levels
NCT00616096 ·Status: COMPLETED ·Phase: NA